Tuberculosis

IDT Biologika acquires Aeras’ vaccine manufacturing facility

IDT Biologika acquires Aeras’ vaccine manufacturing facility

By Zachary Brennan

Vaccine developer Aeras and CMO (contract manufacturing organization) IDT Biologika have formed a strategic partnership that includes the acquisition of Aeras's Biopharmaceutical Development Center (BDC) manufacturing facility by IDT. 

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers